Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
B-Cell Malignancies
Interventions
DRUG

Parsaclisib

Participants will continue on the same dose (1,2.5,5 OR 20 mg) and schedule of parsaclisib as that provided in the parent Protocol at the time of the rollover.

DRUG

parsaclisib + itacitinib

Participants will continue on the same dose (1,2.5,5 OR 20 mg) and schedule of parsaclisib and 100 mg of itacitinib as that provided in the parent Protocol at the time of the rollover.

DRUG

parsaclisib + ruxolitinib

Participants will continue on the same dose (1,2.5,5 OR 20 mg) and schedule of parsaclisib and the same dose of ruxolitinib that was provided in the parent Protocol at the time of the rollover.

DRUG

parsaclisib + ibrutinib

Participants will continue on the same dose (1,2.5,5 OR 20 mg) and schedule of parsaclisib and 140 mg of ibrutinib as that provided in the parent Protocol at the time of the rollover.

Trial Locations (105)

10065

Memorial Sloan Kettering Cancer Center, New York

14263

Roswell Park Cancer Institute, Buffalo

15000

Fakultni Nemocnice V Motole, Prague

20122

Fondazione Irccs Ca Granda Ospedale Maggiore, Milan

20133

Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano, Milan

20162

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan

20817

Rcca Md, Llc, Bethesda

22162

Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano, Milan

27710

Duke University Medical Center, Durham

28009

Hospital General Universitario Gregorio Maranon, Madrid

28040

Hospital Universitario Fundacin Jimnez Daz, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28050

Hospital Universitario Hm Sanchinarro, Madrid

28100

Azienda Ospedaliero Universitaria Maggiore Della Carita Di Novara, Novara

28233

Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón

28660

Start Madrid - Ciocc, Boadilla del Monte

29200

Chru de Brest Hospital Morvan, Brest

31010

City of Hope National Medical Center, Duarte

31059

Centre Hospitalier Universitaire de Toulouse, Toulouse

34214

Istanbul Medipol Universitesi Ibagcilar Medipol Mega Universitesi Hastanesi, Istanbul

35040

Ege University Hospital, Izmir

35233

Uab Comprehensive Cancer Center, Birmingham

University of Alabama At Birmingham, Birmingham

37000

Chru Hopitaux de Tours Hospital Bretonneau, Tours

37007

Hospital Clinico Universitario de Salamanca, Salamanca

39401

Hattiesburg Clinic Hematology, Hattiesburg

40126

University of Bologna Institute of Haematology L E A Seragnoli, Bologna

40138

Lstituto Di Ematologia Lorenzo Ea.Seragnoli Universita Degli Studi Di Bologna - Policlinico S. Or, Bologna

41013

Hospital Universitario Virgen Del Rocio, Seville

43210

The Ohio State University, Columbus

44106

University Hospitals Case Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

47014

Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori, Meldola (FC)

48109

University of Michigan Cancer Center, Ann Arbor

48121

Ospedale Santa Maria Delle Croci, Ravenna

49100

Rabin Medical Center - Beilinson Hospital, Petah Tikva

50005

University Hospital Hradec Kralove, Hradec Králové

50134

Azienda Ospedaliero-Universitaria Careggi (Aouc), Florence

56126

Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara, Pisa

60612

Rush University Medical Center-Consultants in Hematology, Chicago

64111

Saint Luke'S Hospital of Kansas City, Kansas City

66205

University of Kansas Hospital Authority, Westwood

66211

Hca Midwest Health-Research Medical Center, Kansas City

75010

Ap-Hp Groupe Hospitalier Saint-Louis Lariboisiere Fernand-Widal Site Saint Louis (Paris), Paris

75013

Hospital Universitaire Pitie-Salpetriere, Paris

75246

Baylor Scott White Univeristy Medical Center, Dallas

80012

Rocky Mountain Cancer Center, Aurora

80131

Universita Di Napoli Federico Ii, Naples

85054

Mayo Clinic Rochester, Phoenix

85719

University of Arizona Cancer Center-Out Pt., Tucson

89169

Comprehensive Cancer Centers of Nevada, Las Vegas

90146

Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello, Palermo

90805

Innovative Clinical Research Institute, Long Beach

91120

Hadassah Hebrew University Medical Center Ein Karem Hadassah, Jerusalem

93720

California Cancer Associates For Research and Excellence, Fresno

97239

Knight Cancer Institute At Oregon Health and Science University, Portland

5265601

Sheba Medical Center, Tel Litwinsky

02114

Massachusetts General Hospital, Boston

98109-4405

University of Washington-Seattle Cancer Care Alliance, Seattle

01090

Medical University of Vienna, Vienna

01200

Cliniques Universitaires Ucl Saint-Luc, Brussels

09000

Universitair Ziekenhuis Gent (Uz Gent), Ghent

08500

Az Groeninge, Kortrijk

03000

Universitaire Ziekenhuis Leuven - Gasthuisberg, Leuven

128 00

Univerzita Karlova V Praze 1. Lekarska Fakulta, Prague

Unknown

University Hospital Kralovkse Vinohrady, Prague

08200

Aarhus University Hospital, Århus N

02100

Rigshospitalet, Copenhagen

04000

Sjaellands Universitetshospital, Roskilde

06189

Centre Antoine Laccassagne, Nice

09024

Petz Aladar County Teaching Hospital, Győr

00144

Ospedale Sant. Eugenio, Roma

113-8431

Juntendo University Hospital, Bunkyō City

104-0045

National Cancer Center Hospital, Chūō

573-1191

Kansai Medical University Hospital, Hirakata

259-1193

Tokai University Hospital, Isehara

650-0047

Irb of Kobe City Medical Center General Hospital, Kobe

602-8566

University Hospital Kyoto Prefectural University of Medicine, Kyoto

399-8701

Nho Matsumoto Medical Center, Matsumoto-shi

981-1293

Miyagi Cancer Center, Miyagi

466-8650

Jrc Aichi Medical Center Nagoya Daini Hospital, Nagoya

951-8566

Niigata Cancer Center Hospital, Niigata

545-8585

Osaka Metropolitan University Hospital, Osaka

003-0006

Hokuyukai Sapporo Hokuyu Hospital, Sapporo

003-0804

National Hospital Org. Hokkaido Cancer Center, Sapporo

980-8574

Tohoku University Hospital, Sendai

160-0023

Tokyo Medical University Hospital, Shinjuku

632-8552

Tenri Hospital, Tenri

113-8603

Nippon Medical School Hospital, Tokyo

221-0855

Yokohama Municipal Citizens Hospital, Yokohama

910-1193

University of Fukui Hospital, Yoshida-gun

05021

Haukeland University Hospital, Bergen

31-501

Sp Zoz Szpital Uniwersytecki, Kracow

93-513

Wwcoit Im. M. Kopernika W Lodzi, Lodz

33-300

Szpital Specjalistyczny Im. Jedrzeja Sniadeckiego W Nowym Saczu, Nowy Sącz

20-081

Samodzielny Publiczny Szpital Kliniczny Nr 1, Wroclaw

06591

The Catholic University of Korea Seoul St. Mary'S Hospital, Seoul

03010

Hospital General Unviersitario de Alicante, Alicante

08916

Germans Trias I Pujol, Badalona

08003

Hospital Del Mar, Barcelona

08036

Hospital Clinic Barcelona, Barcelona

Hospital Clinic I Provincial, Barcelona

08908

Institut Catala Doncologia - Hospital Duran I Reynals, L'Hospitalet de Llobregat

171 76

Karolinska University Hospital Solna, Stockholm

B9 5SS

Birmingham Heartlands Hospital, Birmingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY

NCT04509700 - Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) | Biotech Hunter | Biotech Hunter